Mark Trudeau

More than 25 years in the pharmaceutical industry, with experience in Asia-Pacific, Europe, and North America, in leadership positions for Covidien, Bayer HealthCare, Bristol-Myers Squibb and Abbott Laboratories. Currently, President and CEO, Mallinckrodt Pharmaceuticals; has led the company's transformation to becoming a leading specialty pharmaceutical company, focusing on innovative initiatives to increase competitiveness, while simultaneously executing on product development and acquisitions to build platforms for future growth.

About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum